Raanan Berger

Prof. Raanan Berger is a medical oncologist and radiotherapist at Sheba Medical Center. He serves as the Director of the Cancer Center and heads the clinical research unit. Prof. Berger was recognized in the 2025 Forbes Israel’s “Best Doctors” list.

Oncology Specialization and Approach

Prof. Berger leads the genitourinary oncology program with a primary focus on prostate cancer. He integrates systemic therapy and radiotherapy into a multidisciplinary care model. This approach combines medical treatment with psychological and social support for families. This lets patients receive emotional guidance throughout the process.

The doctor also treats a translational research laboratory. He investigates the molecular mechanisms that drive prostate and breast cancer development. His clinical work includes personalized treatment plans using neuroendoscopic methods for various genitourinary cancers. This work helps identify new ways to treat cancer.

Research and Scientific Contributions

Prof. Berger has co-authored over 20 peer-reviewed scientific publications. His research highlights include:

• Classification studies of high-risk versus very high-risk prostate cancer
• Outcomes of radiotherapy combined with androgen deprivation therapy
• Research on inherited BRCA1 and BRCA2 mutations in large international cohorts
• Study of molecular oncology and tumorigenesis mechanisms

Professional Experience

• Director of the Cancer Center, Sheba Medical Center
• Head of the Clinical Research Unit, Institute of Oncology and Radiotherapy
• Lead of the Genitourinary Oncology Program, Sheba Medical Center

Education and Training

• MD and PhD – School of Medicine, Tel Aviv University, Israel
• Clinical training in Medical Oncology and Radiotherapy – Sheba Medical Center
• Postdoctoral fellowship – Dana-Farber Cancer Institute, Harvard Medical School

During his Harvard fellowship, he focused on prostate cancer treatment with Dr. Philip Kantoff. He also conducted molecular oncology research in the laboratory of Dr. William C. Hahn. This research investigates the genetic causes of tumor growth.

Certifications and Memberships

• Board Certified in Oncology
• European Society for Medical Oncology (ESMO)
• American Society of Clinical Oncology (ASCO)